SNPs for HLA-DQ9.3 need to be designed and assayed in Asian population. Reference: Wang H et al. Serological screening for celiac disease in adult Chinese patients with diarrhea predominant irritable bowel syndrome. Medicine (Baltimore). 2015 Oct;94(42):e1779.
The second problem with design is the stratification of the risk. In reference 2 used for the study, stratification of the risk of CD was done for an at-risk U.S. population. The risk stratification is specific for each population, perhaps the studied U.S. population was principally Caucasian.
Some newer references about celiac disease in China and Japan. 
VERSION 1 -AUTHOR RESPONSE
Response to Reviewer #1 Comment 1: There are a principal and a secondary points which limit the discussion and results referred to the non-European population. The first one are the used SNPs and the second one is the chosen stratification of genetic risk for the serological analyses. No any comments about are done in discussion; also new data about celiac disease in China and Japan need to be included in introduction and discussion.
The principal problem about is the only negative results for East and South Asian and other population. The results could be related to that the used SNPs were developed by Monsuur et al., 2008 (reference 26) for European population.
